Dr. Peter McCullough presentation at 78th Annual Meeting of Association of American Physicians and Surgeons (AAPS)

8:10 mark: “Clinical Concerns [of COVID-19 inoculations]

• mRNA or adenoviral DNA induce production of the Spike protein
  • Cell, tissue, organ endothelial damage
  • Spike protein circulation (body fluids, donated blood)
• No genotoxicity, teratogenicity, or oncogenicity studies
• Concerning ovarian biodistribution study (Pfizer, Japan)
• Concerning reduced fertility study (Moderna, EMA)
• No EAC [external advisory committees], DSMB [Data and Safety Monitoring Board], Human Ethics Committee
• No restriction of properly excluded groups from RCTs [random controlled trials]
  • Pregnant women, women of childbearing potential
  • COVID survivors, previously immune
• No effort to restrict vaccination according to risk for COVID-19 hospitalization or death
• No attempts to present or mitigate risks for public”